2019
DOI: 10.1007/s12029-019-00287-w
|View full text |Cite
|
Sign up to set email alerts
|

An Extraordinary Case of Extranodal Non-Hodgkin’s Lymphoma Presenting as Common Bile Duct Mass

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…In most studies, baseline criteria for administration of tocilizumab were level of CRP ≥100 mg/L (normal values <6 mg/L), ferritin ≥900 ng/mL (normal value <400 ng/mL), LDH >220 U/L, and P/R ratio 200-300 mmHg [18][19][20]24,36,39,40,42 . .However, several studies used baseline criteria for administration of tocilizumab of CRP <100 mg/L and P/F ratio <200 mmHg 23, [30][31][32][33][34]36,43,44 .…”
Section: Discussionmentioning
confidence: 99%
“…In most studies, baseline criteria for administration of tocilizumab were level of CRP ≥100 mg/L (normal values <6 mg/L), ferritin ≥900 ng/mL (normal value <400 ng/mL), LDH >220 U/L, and P/R ratio 200-300 mmHg [18][19][20]24,36,39,40,42 . .However, several studies used baseline criteria for administration of tocilizumab of CRP <100 mg/L and P/F ratio <200 mmHg 23, [30][31][32][33][34]36,43,44 .…”
Section: Discussionmentioning
confidence: 99%